Oramed Pharmaceuticals Inc

ORMP.US
Healthcare · Biotechnology
4.17
+0.01 (+0.24%)
USD · NASDAQ

Company Information

Company Name
Oramed Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US68403P2039
CIK: 0001176309
CUSIP: 68403P104
Currency: USD
Full Time Employees: 0
Phone: 844 967 2633
Fiscal Year End: December
IPO Date: Apr 21, 2006
Description:

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Address:

1185 Avenue of the Americas, New York, NY, United States, 10036

People

Directors & Officers

Name Title Year Born
Mr. Nadav Kidron Esq. President, CEO & Executive Chairman 1974
Mr. Joshua Hexter Chief Operating & Business Officer 1970
Dr. Miriam Kidron Ph.D. Chief Scientific Officer & Director 1940
Mr. Avraham Gabay CFO, Treasurer & Secretary 1986

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 10, 2025 Brad Knott N/A Sale N/A $2.39 N/A
Mar 16, 2023 Nadav Kidron N/A Purchase 26.00K $2.04 $53.04K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BML Capital Management LLC 3.17M Mar 31, 2026 7.74% $6.91 0.00%
Aquamarine Financial (Cayman) Ltd 2.11M Mar 31, 2026 5.16% $0.53 7.06%
Mercer Global Advisors Inc. 1.91M Mar 31, 2026 4.67% $0.01 0.00%
Sb Capital Management Inc 1.90M Dec 31, 2025 4.64% $1.98 0.00%
Gem Investment Advisors, LLC 1.64M Mar 31, 2026 4.01% $5.48 -17.95%
Murchinson Ltd. 1.32M Mar 31, 2026 3.21% $0.57 -1.86%
BOOTHBAY FUND MANAGEMENT, LLC 600.72K Mar 31, 2026 1.47% $0.03 -1.87%
Rathbone Brothers PLC 466.04K Mar 31, 2026 1.14% $0.00 0.00%
Marshall Wace Asset Management Ltd 259.61K Mar 31, 2026 0.63% $0.00 0.21%
Dimensional Fund Advisors, Inc. 158.21K Mar 31, 2026 0.39% $0.00 5.14%
Wells Fargo & Co 157.59K Mar 31, 2026 0.39% $0.00 20.68%
Comprehensive Portfolio Management, LLC 155.48K Mar 31, 2026 0.38% $0.01 0.00%
Renaissance Technologies Corp 147.70K Mar 31, 2026 0.36% $0.00 0.14%
Bank of America Corp 146.15K Mar 31, 2026 0.36% $0.00 2.75%
Susquehanna International Group, LLP 136.22K Mar 31, 2026 0.33% $0.00 424.24%
O'Shaughnessy Asset Management LLC 116.36K Mar 31, 2026 0.28% $0.00 0.00%
Citadel Advisors Llc 98.63K Mar 31, 2026 0.24% $0.00 -49.68%
Hillsdale Investment Management Inc. 97.30K Mar 31, 2026 0.24% $0.01 0.00%
BlackRock Inc 92.19K Mar 31, 2026 0.23% $0.00 2.19%
Jane Street Group LLC 52.54K Mar 31, 2026 0.13% $0.00 -32.86%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Russell 2000 ETF 638.38K 1.56% ▲ 0.60% Jun 30, 2026
2 iShares Russell 2000 Value ETF 316.41K 0.77% ▼ 0.69% Jun 30, 2026
3 Russell 2000 Equity Index Fund B 204.87K 0.50% ▲ 0.00% Jun 30, 2026
4 Russell 2000 Index Non-Lendable Fund 204.87K 0.50% ▲ 0.00% Jun 30, 2026
5 Vanguard Russell 2000 ETF 196.77K 0.48% ▲ 0.00% Jun 30, 2026
6 State St Russell Sm Cap® Idx SL Cl I 126.50K 0.31% ▲ 0.00% Jun 30, 2026
7 iShares Micro-Cap ETF 114.97K 0.28% ▲ 0.00% Jun 30, 2026
8 Schwab Small Cap Index 83.63K 0.20% ▲ 0.00% Jun 30, 2026
9 NT R2000 Index Fund - NL 77.32K 0.19% ▲ 0.00% Jun 30, 2026
10 NT R2000 Index Fund - DC - NL - 3 66.11K 0.16% ▲ 0.00% Jun 30, 2026

Financial Highlights

Market Cap: $170.25M
EBITDA: $-14.13M
P/E Ratio: $1.60
PEG Ratio: $0.00
Book Value: $5.82
Dividend/Share: $0.00
Dividend Yield: 0.00%
Earnings/Share: $2.60
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -4.28%
ROE (TTM): 58.16%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 40.90%
Revenue Growth (YOY): -100.00%

Valuation Metrics

Enterprise Value: $99.85M
Trailing P/E: 1.60
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 40.93M
Shares Float: 31.59M
% Insiders: 1,793.20%
% Institutions: 3,232.80%
Short % Float: 2.21%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$2.00M
Cost of Goods Sold
adjust
$-1.99M
Gross Profit
subtotal
$13.00K
SG&A
adjust
$-8.72M
R&D
adjust
$-6.38M
Operating Income
subtotal
$-15.09M
Other / Non-Operating Items
adjust
$79.14M
Net Income
subtotal
$64.05M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ORMP.US!